This modification renders the peptide resistant to enzymatic degradation, significantly extending its half-life and potency in vivo compared to standard L-peptides
Robichaud S, Fairman G, Vijithakumar V, Mak E, Cook DP, Pelletier AR, Huard S, Vanderhyden BC, Figeys D, Lavalle-Adam M, Baetz K, Ouimet M (2021) Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells
GHK Cu has been studied for use with cancer patients, one study was done with those suffering from colon cancer
186 These findings shed light on the mechanism of lactylation in immunosuppression, metabolic reprogramming, and chemoradiotherapy resistance in GBM, suggesting that targeting glycolysis-derived lactylation could be a potential combined therapeutic strategy for GBM
WHAT TO EXPECT GHK-Cu therapy at ELITE Sports Medicine includes: Eligibility is determined following consultation and clinical assessment.
